<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1531" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1531/" /><meta name="ncbi_pagename" content="Waardenburg Syndrome Type I - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Waardenburg Syndrome Type I - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Waardenburg Syndrome Type I" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/05/04" /><meta name="citation_author" content="Jeff Mark Milunsky" /><meta name="citation_pmid" content="20301703" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1531/" /><meta name="citation_keywords" content="Paired box protein Pax-3" /><meta name="citation_keywords" content="PAX3" /><meta name="citation_keywords" content="Waardenburg Syndrome Type I" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Waardenburg Syndrome Type I" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Jeff Mark Milunsky" /><meta name="DC.Date" content="2017/05/04" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1531/" /><meta name="description" content="Waardenburg syndrome type I (WS1) is an auditory-pigmentary disorder comprising congenital sensorineural hearing loss and pigmentary disturbances of the iris, hair, and skin, along with dystopia canthorum (lateral displacement of the inner canthi). The hearing loss in WS1, observed in approximately 60% of affected individuals, is congenital, typically non-progressive, either unilateral or bilateral, and sensorineural. Most commonly, hearing loss in WS1 is bilateral and profound (&gt;100 dB). The majority of individuals with WS1 have either a white forelock or early graying of the scalp hair before age 30 years. The classic white forelock observed in approximately 45% of individuals is the most common hair pigmentation anomaly seen in WS1. Affected individuals may have complete heterochromia iridium, partial/segmental heterochromia, or hypoplastic or brilliant blue irides. Congenital leukoderma is frequently seen on the face, trunk, or limbs." /><meta name="og:title" content="Waardenburg Syndrome Type I" /><meta name="og:type" content="book" /><meta name="og:description" content="Waardenburg syndrome type I (WS1) is an auditory-pigmentary disorder comprising congenital sensorineural hearing loss and pigmentary disturbances of the iris, hair, and skin, along with dystopia canthorum (lateral displacement of the inner canthi). The hearing loss in WS1, observed in approximately 60% of affected individuals, is congenital, typically non-progressive, either unilateral or bilateral, and sensorineural. Most commonly, hearing loss in WS1 is bilateral and profound (&gt;100 dB). The majority of individuals with WS1 have either a white forelock or early graying of the scalp hair before age 30 years. The classic white forelock observed in approximately 45% of individuals is the most common hair pigmentation anomaly seen in WS1. Affected individuals may have complete heterochromia iridium, partial/segmental heterochromia, or hypoplastic or brilliant blue irides. Congenital leukoderma is frequently seen on the face, trunk, or limbs." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1531/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ws1/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1531/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D7591E0415381000000000A0503E2.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1531_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1531_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/wfs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/warsaw/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1531_"><span class="title" itemprop="name">Waardenburg Syndrome Type I</span></h1><p class="contrib-group"><span itemprop="author">Jeff Mark Milunsky</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1531_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1531_ai__"><div class="contrib half_rhythm"><span itemprop="author">Jeff Mark Milunsky</span>, MD<div class="affiliation small">Director, Clinical Genetics<br />Senior Director, Molecular Genetics<br />Co-Director, Center for Human Genetics, Inc<br />Cambridge, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cnighc@yksnulimj" class="oemail">gro.cnighc@yksnulimj</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 30, 2001</span>; Last Revision: <span itemprop="dateModified">May 4, 2017</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ws1.Summary" itemprop="description"><h2 id="_ws1_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Waardenburg syndrome type I (WS1) is an auditory-pigmentary disorder comprising <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> sensorineural hearing loss and pigmentary disturbances of the iris, hair, and skin, along with dystopia canthorum (lateral displacement of the inner canthi). The hearing loss in WS1, observed in approximately 60% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, is congenital, typically non-progressive, either unilateral or bilateral, and sensorineural. Most commonly, hearing loss in WS1 is bilateral and profound (&#x0003e;100 dB). The majority of individuals with WS1 have either a white forelock or early graying of the scalp hair before age 30 years. The classic white forelock observed in approximately 45% of individuals is the most common hair pigmentation anomaly seen in WS1. Affected individuals may have complete heterochromia iridium, partial/segmental heterochromia, or hypoplastic or brilliant blue irides. Congenital leukoderma is frequently seen on the face, trunk, or limbs.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of WS1 is established in most individuals by physical examination for clinical criteria including: sensorineural hearing loss, pigmentary changes in the hair and eyes, dystopia canthorum identified by calculation of the W index, and specific facial features. Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>PAX3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> establishes the diagnosis if clinical features are inconclusive.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management of the hearing loss depends on its severity; cochlear implantation has been successfully used in individuals with WS1.</p><p><i>Evaluation of relatives at risk:</i> If the family-specific <i>PAX3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of relatives at risk allows for early screening of those at risk for hearing loss.</p><p><i>Pregnancy management:</i> Folic acid supplementation in pregnancy is recommended for women at increased risk of having a child with WS1 because of possibly increased risk for neural tube defects in association with WS1.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Waardenburg syndrome type I (WS1) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The majority of probands have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. A minority of probands do not have an affected parent and are presumed to have WS1 as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Offspring of an individual with WS1 have a 50% chance of inheriting the pathogenic variant. If the pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing for this disease/<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or <a class="def" href="/books/n/gene/glossary/def-item/custom-prenatal-testing/">custom prenatal testing</a>. Although this testing can determine whether the fetus has inherited the <i>PAX3</i> pathogenic variant, it cannot determine the clinical manifestations or their severity.</p></div></div><div id="ws1.Diagnosis"><h2 id="_ws1_Diagnosis_">Diagnosis</h2><div id="ws1.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Waardenburg syndrome type I (WS1) <b>should be suspected</b> in individuals with several of the following major and minor criteria.</p><p><b>Major criteria</b></p><ul><li class="half_rhythm"><div>Congenital sensorineural hearing loss</div></li><li class="half_rhythm"><div>White forelock, hair hypopigmentation</div></li><li class="half_rhythm"><div>Pigmentation abnormality of the iris:</div><ul><li class="half_rhythm"><div>Complete heterochromia iridum (irides of different color)</div></li><li class="half_rhythm"><div>Partial/segmental heterochromia (two different colors in same iris, typically brown and blue)</div></li><li class="half_rhythm"><div>Hypoplastic blue irides or brilliant blue irides</div></li></ul></li><li class="half_rhythm"><div>Dystopia canthorum, W index &#x0003e;1.95&#x000a0;*</div></li><li class="half_rhythm"><div>Affected <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a></div></li></ul><p><b>Minor criteria</b></p><ul><li class="half_rhythm"><div>Skin hypopigmentation (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> leukoderma)</div></li><li class="half_rhythm"><div>Synophrys and/or medial eyebrow flare</div></li><li class="half_rhythm"><div>Broad/high nasal root, low-hanging columella</div></li><li class="half_rhythm"><div>Underdeveloped alae nasi</div></li><li class="half_rhythm"><div>Premature gray hair (age &#x0003c;30 years)</div></li></ul><p>* Note: The measurements necessary to calculate the W index (in mm) are as follows: inner canthal distance (a), interpupillary distance (b), and outer canthal distance (c).</p><p>Calculate X = (2a &#x02013; (0.2119c + 3.909))/c</p><p>Calculate Y = (2a &#x02013; (0.2479b + 3.909))/b</p><p>Calculate W = X + Y + a/b</p><p>Click <a href="/books/NBK1531/bin/ws1-W_index_calculator.xlsx">here</a> to download a tool (xlsx) for calculating the W index.</p></div><div id="ws1.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of WS1 <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with two major criteria or one major plus two minor criteria (see <a href="#ws1.Suggestive_Findings">Suggestive Findings</a>) as proposed by the Waardenburg Consortium [<a class="bk_pop" href="#ws1.REF.farrer.1992.902">Farrer et al 1992</a>].</p><p>Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PAX3</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1531/table/ws1.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figws1Tmoleculargenetictestingusedin" rid-ob="figobws1Tmoleculargenetictestingusedin">Table 1</a>) confirms the diagnosis if clinical features are inconclusive.</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, <b>a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>PAX3</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>PAX3</i> and other genes of interest (see <a href="#ws1.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>PAX3</i>) fails to confirm a diagnosis in an individual with features of WS1. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="ws1.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Waardenburg Syndrome Type I</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1531/table/ws1.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ws1.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PAX3</i></td><td headers="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;90%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~6%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ws1.TF.1.1"><p class="no_margin">See <a href="/books/NBK1531/#ws1.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ws1.TF.1.2"><p class="no_margin">See <a href="#ws1.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="ws1.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="ws1.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#ws1.REF.pingault.2010.391">Pingault et al [2010]</a>, Milunsky [2011, unpublished data], <a class="bk_pop" href="#ws1.REF.wildhardt.2013">Wildhardt et al [2013]</a></p></div></dd><dt>5. </dt><dd><div id="ws1.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="ws1.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#ws1.REF.milunsky.2007.179">Milunsky et al [2007]</a>. Note: No duplications have been reported.</p></div></dd></dl></div></div></div></div></div><div id="ws1.Clinical_Characteristics"><h2 id="_ws1_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ws1.Clinical_Description"><h3>Clinical Description</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Waardenburg syndrome type I (WS1) is variable even within a family. <a class="bk_pop" href="#ws1.REF.liu.1995.95">Liu et al [1995]</a> summarized the <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> (percentage) of clinical features of WS1 (see <a class="figpopup" href="/books/NBK1531/table/ws1.T.penetrance_of_individuals_with_waa/?report=objectonly" target="object" rid-figpopup="figws1Tpenetranceofindividualswithwaa" rid-ob="figobws1Tpenetranceofindividualswithwaa">Table 2</a>) in 60 individuals with WS1 and 210 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported elsewhere in the literature. <a class="bk_pop" href="#ws1.REF.newton.2002.201">Newton [2002]</a> reviewed the clinical features of the Waardenburg syndromes and <a class="bk_pop" href="#ws1.REF.tamayo.2008.1026">Tamayo et al [2008]</a> discussed their screening program for Waardenburg syndrome in Colombia, detailing the percentage of each clinical manifestation; percentages similar to those found in the <a class="bk_pop" href="#ws1.REF.liu.1995.95">Liu et al [1995]</a> study were documented. However, ascertainment bias was evident, as all 95 affected individuals had hearing loss and were among the institutionalized deaf population in Colombia.</p><div id="ws1.T.penetrance_of_individuals_with_waa" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Penetrance of Individuals with Waardenburg Syndrome Type I with Characteristic Clinical Findings</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1531/table/ws1.T.penetrance_of_individuals_with_waa/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ws1.T.penetrance_of_individuals_with_waa_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Finding</th><th id="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">% of Affected Individuals</th></tr></thead><tbody><tr><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sensorineural hearing loss</td><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">47%-58%</td></tr><tr><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Heterochromic irides</td><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%-31%</td></tr><tr><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypoplastic blue irides</td><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%-18%</td></tr><tr><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">White forelock</td><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">43%-48%</td></tr><tr><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early graying</td><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23%-38%</td></tr><tr><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Leukoderma</td><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22%-36%</td></tr><tr><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">High nasal root</td><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">52%-100%</td></tr><tr><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Medial eyebrow flare</td><td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">63%-73%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Based on <a class="bk_pop" href="#ws1.REF.liu.1995.95">Liu et al [1995]</a>, <a class="bk_pop" href="#ws1.REF.pardono.2003.223">Pardono et al [2003]</a>, <a class="bk_pop" href="#ws1.REF.tamayo.2008.1026">Tamayo et al [2008]</a></p></div></dd></dl></div></div></div><p><b>Hearing loss.</b> The hearing loss in WS1 is <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>, typically non-progressive, either unilateral or bilateral, and of the sensorineural type. The most common type in WS1 is profound bilateral hearing loss (&#x0003e;100 dB). The laterality of the hearing loss shows both inter- and intrafamilial variation.</p><p>Various temporal bone abnormalities have been identified in persons with WS1 and hearing loss [<a class="bk_pop" href="#ws1.REF.madden.2003.2035">Madden et al 2003</a>]. The temporal bone abnormalities include enlargement of the vestibular aqueduct and upper vestibule, narrowing of the internal auditory canal porus, and hypoplasia of the modiolus.</p><p><b>Hair color.</b> The classic white forelock is the most common hair pigmentation anomaly seen in WS1; it may be present at birth, or appear later, typically in the teen years. The white forelock may become normally pigmented over time. The white forelock is typically in the midline but the patch of white hair may also be elsewhere. In evaluating an individual with suspected WS1 without a white forelock, the individual should be asked whether the hair has been dyed. Red and black forelocks have also been described. The majority of individuals with WS1 have either a white forelock or early graying of scalp hair before age 30 years [<a class="bk_pop" href="#ws1.REF.farrer.1992.902">Farrer et al 1992</a>].</p><p>The hypopigmentation can also involve the eyebrows and eyelashes.</p><p><b>Ocular findings.</b> Individuals with WS1 may have a variety of ocular pigmentary manifestations. The most commonly observed are complete or segmental heterochromia or hypoplastic or brilliant blue irides. Iris and choroidal hypopigmentation (sector pattern more than diffuse pattern) has been described [<a class="bk_pop" href="#ws1.REF.shields.2013.1167">Shields et al 2013</a>]. Visual acuity does not differ from the general population.</p><p><b>Skin pigmentation.</b> Congenital leukoderma (white skin patches) is frequently seen in WS1 on the face, trunk, or limbs. These areas of hypopigmentation frequently have hyperpigmented borders and may be associated with an adjacent white forelock.</p><p><b>Occasional findings</b> identified in multiple families (although too few to determine the percentage occurrence in this disorder):</p><ul><li class="half_rhythm"><div>Cleft lip and palate</div></li><li class="half_rhythm"><div>Spina bifida, a finding that is not surprising given that WS1 is considered a neurocristopathy with <i>PAX3</i> being expressed in the neural crest. <a class="bk_pop" href="#ws1.REF.kujat.2007.155">Kujat et al [2007]</a> described the <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> of spina bifida in a family with WS1. <a class="bk_pop" href="#ws1.REF.lemay.2015.493">Lemay et al [2015]</a> reported a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> <i>PAX3</i> variant in an individual with myelomeningocele and WS1.</div></li><li class="half_rhythm"><div>Vestibular symptoms including vertigo, dizziness, and balance difficulties, even without hearing loss [<a class="bk_pop" href="#ws1.REF.black.2001.188">Black et al 2001</a>]</div></li></ul><p><b>Otopathology.</b> The otopathology of an individual with WS1 and a <i>PAX3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been described [<a class="bk_pop" href="#ws1.REF.merchant.2001.875">Merchant et al 2001</a>]. The findings are consistent with defective melanocyte migration or function resulting in defective development of the stria vascularis leading to sensorineural hearing loss.</p></div><div id="ws1.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><b><i>PAX3.</i></b> Genotype/<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations in <i>PAX3</i> are not well established except for the p.Asn47His <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, which causes WS3 [<a class="bk_pop" href="#ws1.REF.hoth.1993.455">Hoth et al 1993</a>], and the p.Asn47Lys pathogenic variant described in craniofacial-deafness-hand syndrome [<a class="bk_pop" href="#ws1.REF.asher.1996.30">Asher et al 1996</a>]. <a class="bk_pop" href="#ws1.REF.destefano.1998.499">DeStefano et al [1998]</a> found that the presence of pigmentary disturbances in individuals with WS1 correlated more with <i>PAX3</i> pathogenic variants that delete the homeodomain than with <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> pathogenic variants that include the paired <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. No <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-phenotype correlation for the hearing loss in WS1 has been found.</p><p><b><i>PAX3</i> partial- or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions.</b> There appears to be no discernable difference in the severity associated with whole- or partial-gene deletions and the clinical spectrum reported for small intragenic <i>PAX3</i> pathogenic variants [<a class="bk_pop" href="#ws1.REF.milunsky.2007.179">Milunsky et al 2007</a>].</p><p><b><i>PAX3</i> and <i>MITF</i> double heterozygotes (Waardenburg syndrome type I and Waardenburg syndrome type II [WS2] combined <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)<i>.</i></b>
<a class="bk_pop" href="#ws1.REF.yang.2013.e77149">Yang et al [2013]</a> reported a family in which one parent had WS1 due to a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PAX3</i> and the other parent had WS2 (see <a href="#ws1.Differential_Diagnosis">Differential Diagnosis</a>) due to a heterozygous pathogenic variant in <i>MITF</i>. Their child was heterozygous for both pathogenic variants and had significantly more pigmentary findings (i.e., white forelock, white eyebrows/eyelashes, and leukoderma) than either parent.</p></div><div id="ws1.Penetrance"><h3>Penetrance</h3><p>WS1 showed <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of at least 85% [<a class="bk_pop" href="#ws1.REF.preus.1983.383">Preus et al 1983</a>] before the advent of molecular testing. Careful examination of individuals identified on the basis of <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> analysis as having a <i>PAX3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> usually reveals subtle findings (minor criteria). Hence, those individuals with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a> should be examined closely as the penetrance is likely almost complete.</p></div><div id="ws1.Prevalence"><h3>Prevalence</h3><p>It is difficult to quote a figure for the prevalence of WS1 without population-based molecular analysis. The prevalence figures vary from 1:20,000 to 1:40,000, accounting for approximately 3% of congenitally deaf children [<a class="bk_pop" href="#ws1.REF.tamayo.2008.1026">Tamayo et al 2008</a>].</p></div></div><div id="ws1.Genetically_Related_Allelic_Disorder"><h2 id="_ws1_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p><b>Germline <i>PAX3</i> pathogenic variants</b> also cause the following:</p><ul><li class="half_rhythm"><div>Waardenburg syndrome type III (WS3) (Klein-Waardenburg syndrome), characterized by a combination of typical WS1 features and hypoplasia or contractures of the limb muscles or joints, carpal bone fusion, or syndactyly [<a class="bk_pop" href="#ws1.REF.hoth.1993.455">Hoth et al 1993</a>]. In a <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> Turkish family, both parents who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <i>PAX3</i> p.Tyr90His <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have WS1; their child who is <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the p.Tyr90His pathogenic variant has WS3 [<a class="bk_pop" href="#ws1.REF.wollnik.2003.42">Wollnik et al 2003</a>].</div></li><li class="half_rhythm"><div>Craniofacial-deafness-hand syndrome (CDHS) (OMIM <a href="http://www.omim.org/entry/122880" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">122880</a>), characterized by a flat facial profile, widely spaced eyes, hypoplastic nose with slit-like nares, and sensorineural hearing loss. X-ray findings include a small maxilla, absent or small nasal bones, and ulnar deviation of the hands [<a class="bk_pop" href="#ws1.REF.sommer.2003.91">Sommer &#x00026; Bartholomew 2003</a>]. <a class="bk_pop" href="#ws1.REF.asher.1996.30">Asher et al [1996]</a> identified a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant in <i>PAX3</i> in individuals with this disorder. CDHS is apparently distinct from both WS1 and WS3. <a class="bk_pop" href="#ws1.REF.gad.2008.1880">Gad et al [2008]</a> reported a woman who shares some, but not all features of WS3 and CDHS, and who also has abnormal cranial bones (hypoplastic sinuses and small cochlea). Whereas no <a class="def" href="/books/n/gene/glossary/def-item/sequence-alteration/">sequence alteration</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>PAX3</i> was found, partial-gene deletions were not ruled out. The authors suggest genetic heterogeneity even within the CDHS subtype.</div></li></ul></div><div id="ws1.Differential_Diagnosis"><h2 id="_ws1_Differential_Diagnosis_">Differential Diagnosis</h2><p>Waardenburg syndrome type I (WS1) needs to be differentiated from other causes of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>, non-progressive sensorineural hearing loss (see <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>) and from other forms of Waardenburg syndrome.</p><p><b>Waardenburg syndrome type II (WS2).</b> WS1 is distinguished from WS2 by the presence in WS1 of lateral displacement of the inner canthi (dystopia canthorum). If the average W index across a family is less than 1.95, the diagnosis is WS2. Sensorineural hearing loss and heterochromia iridum are the two most characteristic features of WS2. Both are more common in WS2 than WS1. White forelock and leukoderma are both more common in WS1 than in WS2 (see <a class="figpopup" href="/books/NBK1531/table/ws1.T.comparison_of_clinical_features_in/?report=objectonly" target="object" rid-figpopup="figws1Tcomparisonofclinicalfeaturesin" rid-ob="figobws1Tcomparisonofclinicalfeaturesin">Table 3</a>).</p><ul><li class="half_rhythm"><div><b><i>MITF</i></b> (OMIM <a href="http://omim.org/entry/156845" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">156845</a>). Heterozygous <i>MITF</i> pathogenic variants [<a class="bk_pop" href="#ws1.REF.yang.2013.e77149">Yang et al 2013</a>] have been described in approximately 10%-20% of individuals with WS2. <i>MITF</i> pathogenic variants have also been identified in individuals with Tietz syndrome (deafness with uniform hypopigmentation) [<a class="bk_pop" href="#ws1.REF.l_ger.2012.584">L&#x000e9;ger et al 2012</a>].</div></li><li class="half_rhythm"><div><b><i>SOX10</i></b> (OMIM <a href="http://omim.org/entry/602229" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">602229</a>). Heterozygous <i>SOX10</i> single-nucleotide variants [<a class="bk_pop" href="#ws1.REF.iso.2008.2162">Iso et al 2008</a>] and deletions [<a class="bk_pop" href="#ws1.REF.bondurand.2007.1169">Bondurand et al 2007</a>, <a class="bk_pop" href="#ws1.REF.brezo.2014.1512">Brezo et al 2014</a>] have been described in about 15% of individuals with WS2. <a class="bk_pop" href="#ws1.REF.chen.2010.70">Chen et al [2010]</a> indicated that <i>SOX10</i> pathogenic variants occurred with a frequency similar to <i>MITF</i> pathogenic variants in individuals with WS2 of Chinese ancestry. Temporal bone abnormalities (specifically bilateral agenesis or hypoplasia of the semicircular canals with a cochlear deformity and enlarged vestibule) are also found in individuals with <i>SOX10</i> pathogenic variants [<a class="bk_pop" href="#ws1.REF.elmalehberg_s.2013.1257">Elmaleh-Berg&#x000e8;s et al 2013</a>]. <a class="bk_pop" href="#ws1.REF.zhang.2012.491">Zhang et al [2012]</a> and <a class="bk_pop" href="#ws1.REF.chaoui.2011.1436">Chaoui et al [2011]</a> performed functional analysis of <i>SOX10</i> pathogenic variants. A <a class="def" href="/books/n/gene/glossary/def-item/frameshift-variant/">frameshift variant</a> showed a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect on wild type <i>SOX10</i>, leading to faster protein decay, possibly resulting in a milder WS2 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#ws1.REF.zhang.2012.491">Zhang et al 2012</a>].</div></li><li class="half_rhythm"><div><b><i>SNAI2.</i></b> Biallelic <i>SNAI2</i> pathogenic variants were reported in two individuals with features overlapping WS2 (OMIM <a href="http://omim.org/entry/608890" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">608890</a>)</div></li></ul><div id="ws1.T.comparison_of_clinical_features_in" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Comparison of Clinical Features in WS1 and WS2</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1531/table/ws1.T.comparison_of_clinical_features_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ws1.T.comparison_of_clinical_features_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Clinical Finding</th><th id="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">% of Affected Individuals</th></tr><tr><th headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2" id="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">WS1</th><th headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2" id="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">WS2</th></tr></thead><tbody><tr><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sensorineural hearing loss</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">47%-58%</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">77%-80%</td></tr><tr><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Heterochromic irides</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%-31%</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">42%-54%</td></tr><tr><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypoplastic blue irides</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%-18%</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3%-23%</td></tr><tr><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">White forelock</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">43%-48%</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">16%-23%</td></tr><tr><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early graying</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23%-38%</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14%-30%</td></tr><tr><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Leukoderma</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22%-36%</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%-12%</td></tr><tr><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">High nasal root</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">52%-100%</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0%-14%</td></tr><tr><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Medial eyebrow flare</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">63%-73%</td><td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7%-12%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Based on <a class="bk_pop" href="#ws1.REF.liu.1995.95">Liu et al [1995]</a>, <a class="bk_pop" href="#ws1.REF.pardono.2003.223">Pardono et al [2003]</a>, <a class="bk_pop" href="#ws1.REF.tamayo.2008.1026">Tamayo et al [2008]</a></p></div></dd></dl></div></div></div><p><b>Waardenburg syndrome type IV (WS4).</b> Individuals having a rare combination of pigmentary abnormalities, hearing loss, and <a href="/books/n/gene/hirschsprung-ov/">Hirschsprung disease</a> have WS4 [<a class="bk_pop" href="#ws1.REF.jan.2008.744">Jan et al 2008</a>] caused by pathogenic variants in one of the following genes: <i>EDNRB</i> (OMIM <a href="http://omim.org/entry/131244" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">131244</a>), <i>EDN3</i> [<a class="bk_pop" href="#ws1.REF.ohtani.2006.491">Ohtani et al 2006</a>] (OMIM <a href="http://omim.org/entry/613265" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613265</a>), or <i>SOX10</i> [<a class="bk_pop" href="#ws1.REF.bondurand.2007.1169">Bondurand et al 2007</a>, <a class="bk_pop" href="#ws1.REF.sznajer.2008.1038">Sznajer et al 2008</a>] (OMIM <a href="http://omim.org/entry/602229" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">602229</a>).</p><p>See Waardenburg syndrome: <a href="http://www.omim.org/phenotypicSeries/PS193500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM Phenotypic Series</a> to view genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p><p><b>Piebaldism</b> (OMIM <a href="http://omim.org/entry/172800" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">172800</a>). Piebaldism has some pigmentary features in common with Waardenburg syndrome. A white forelock is commonly seen along with absent pigmentation of the medial forehead and eyebrows. Absent pigmentation of the chest, abdomen, and limbs is also common. A characteristic feature is hyperpigmented borders surrounding the unpigmented areas. Heterochromia irides and sensorineural deafness are rarely described. This disorder has shown genetic heterogeneity with dominant <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants/whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions described involving the <i>KIT</i> proto-oncogene. Heterozygous pathogenic variants in <i>SNAI2</i> have also been implicated as an etiology in some individuals with piebaldism [<a class="bk_pop" href="#ws1.REF.s_nchezmart_n.2003.125">S&#x000e1;nchez-Mart&#x000ed;n et al 2003</a>].</p></div><div id="ws1.Management"><h2 id="_ws1_Management_">Management</h2><div id="ws1.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Audiology evaluation</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="ws1.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Management of the hearing loss associated with WS1 depends on its severity (see <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>). Cochlear implantation has been successful in individuals with WS [<a class="bk_pop" href="#ws1.REF.amirsalari.2012.2179">Amirsalari et al 2012</a>, <a class="bk_pop" href="#ws1.REF.de_sousa_andrade.2012.1375">de Sousa Andrade et al 2012</a>, <a class="bk_pop" href="#ws1.REF.koyama.2016.2854736">Koyama et al 2016</a>].</p></div><div id="ws1.Surveillance"><h3>Surveillance</h3><p>The hearing loss in WS1 is typically non-progressive. Hence, repeat audiogram would usually not be necessary.</p></div><div id="ws1.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual to allow early screening of those at risk for hearing loss. Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known;</div></li><li class="half_rhythm"><div>Physical examination for the clinical features of WS1 and audiology evaluation if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known.</div></li></ul><p>See <a href="#ws1.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ws1.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Folic acid supplementation in pregnancy has been recommended for women at increased risk of having a child with WS1, given the possibly increased risk of neural tube defects in association with WS1 [<a class="bk_pop" href="#ws1.REF.fleming.1998.2107">Fleming &#x00026; Copp 1998</a>]; however, no human studies have addressed the ideal dose of folic acid to be used during pregnancy.</p></div><div id="ws1.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="ws1.Genetic_Counseling"><h2 id="_ws1_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ws1.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Waardenburg syndrome type I (WS1) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="ws1.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The majority of individuals diagnosed with WS1 have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A minority of individuals diagnosed with WS1 do not have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent and are presumed to have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The mutation rate has been estimated at 0.4 per 100,000 [<a class="bk_pop" href="#ws1.REF.waardenburg.1951.195">Waardenburg 1951</a>]. <a class="bk_pop" href="#ws1.REF.jones.1975.84">Jones et al [1975]</a> found evidence of advanced paternal age effect in <i>de novo</i> pathogenic variants of WS1.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include examination for clinical manifestations of WS1 by: assessing the facial features, calculating the W index, examining the skin and hair for hypopigmentation, and obtaining an audiogram.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (germline mosaicism has been reported [<a class="bk_pop" href="#ws1.REF.kapur.1991.194">Kapur &#x00026; Karam 1991</a>]).</div></li><li class="half_rhythm"><div>Evaluation of parents may determine that one is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> but has escaped previous diagnosis because of a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a <i>PAX3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is low.</div></li><li class="half_rhythm"><div>If the <i>PAX3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#ws1.REF.kapur.1991.194">Kapur &#x00026; Karam 1991</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with WS1 has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>The clinical manifestations in the offspring cannot be predicted and range from mild or subclinical features through the classic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of WS1, including deafness.</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members are at risk.</p></div><div id="ws1.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#ws1.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk of being affected.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ws1.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>PAX3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for WS1 are possible. Although such testing can determine whether the <i>PAX3</i> pathogenic variant has been inherited, the results of such testing cannot be used to predict clinical manifestations or their severity.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="ws1.Resources"><h2 id="_ws1_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=waardenburgsyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Waardenburg syndrome</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22267/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Waardenburg syndrome</a></div></li><li class="half_rhythm"><div><b>American Society for Deaf Children (ASDC)</b></div><div>800 Florida Avenue Northeast</div><div>Suite 2047</div><div>Washington DC 20002-3695</div><div><b>Phone:</b> 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)</div><div><b>Fax:</b> 410-795-0965</div><div><b>Email:</b> info@deafchildren.org; asdc@deafchildren.org</div><div><a href="http://www.deafchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.deafchildren.org</a></div></li><li class="half_rhythm"><div><b>BabyHearing.org</b></div><div><i>This site, developed with support from the National Institute on Deafness and Other Communication Disorders, provides information about newborn hearing screening and hearing loss.</i></div><div><a href="http://www.babyhearing.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.babyhearing.org</a></div></li><li class="half_rhythm"><div><b>Hereditary Hearing Loss Homepage</b></div><div><a href="http://hereditaryhearingloss.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">hereditaryhearingloss.org</a></div></li><li class="half_rhythm"><div><b>National Association of the Deaf (NAD)</b></div><div>8630 Fenton Street</div><div>Suite 820</div><div>Silver Spring MD 20910</div><div><b>Phone:</b> 301-587-1788; 301-587-1789 (TTY)</div><div><b>Fax:</b> 301-587-1791</div><div><b>Email:</b> nad.info@nad.org</div><div><a href="http://www.nad.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nad.org</a></div></li><li class="half_rhythm"><div><b>National Organization of Albinism and Hypopigmentation (NOAH)</b></div><div>PO Box 959</div><div>East Hampstead NH 03826-0959</div><div><b>Phone:</b> 800-473-2310 (toll-free); 603-887-2310</div><div><b>Fax:</b> 800-648-2310 (toll-free)</div><div><b>Email:</b> info@albinism.org</div><div><a href="http://www.albinism.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.albinism.org</a></div></li></ul></div><div id="ws1.Molecular_Genetics"><h2 id="_ws1_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ws1.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Waardenburg Syndrome Type I: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1531/table/ws1.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ws1.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ws1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ws1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ws1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ws1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ws1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ws1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ws1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5077" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PAX3</i></a></td><td headers="hd_b_ws1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5077" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q36<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_ws1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P23760" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Paired box protein Pax-3</a></td><td headers="hd_b_ws1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://deafnessvariationdatabase.org/gene_page/PAX3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Deafness Variation Database - PAX3</a><br /><a href="https://databases.lovd.nl/shared/genes/PAX3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PAX3 gene database</a></td><td headers="hd_b_ws1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PAX3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PAX3</a></td><td headers="hd_b_ws1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PAX3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PAX3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ws1.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ws1.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Waardenburg Syndrome Type I (<a href="/omim/193500,606597" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1531/table/ws1.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ws1.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/193500" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">193500</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">WAARDENBURG SYNDROME, TYPE 1; WS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606597" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606597</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PAIRED BOX GENE 3; PAX3</td></tr></tbody></table></div></div><div id="ws1.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p><i>PAX3</i> is one of a family of nine human <i>PAX</i> genes coding for DNA-binding transcription factors that are expressed in the early embryo. The <i>PAX</i> genes are defined by the presence of a paired box (128-amino acid DNA-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>). In addition, <i>PAX3</i> contains a homeobox [<a class="bk_pop" href="#ws1.REF.birrane.2009.1148">Birrane et al 2009</a>].</p><p><b>Gene structure.</b>
<i>PAX3</i> has a number of transcript variants that encode different <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> (see <a href="/books/NBK1531/#ws1.molgen.TA">Table A</a>, <b>Gene</b>). <i>PAX3</i> has ten exons, with the paired box in exons 2-4 and the homeobox in exons 5 and 6 [<a class="bk_pop" href="#ws1.REF.birrane.2009.1148">Birrane et al 2009</a>], and encodes paired box protein Pax-3.</p><p><b>Pathogenic variants.</b> Pathogenic variants within <i>PAX3</i> or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> result in <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>. Pathogenic variants within <i>PAX3</i> causing Waardenburg syndrome type I (WS1) were first described in 1992 [<a class="bk_pop" href="#ws1.REF.baldwin.1992.637">Baldwin et al 1992</a>, <a class="bk_pop" href="#ws1.REF.tassabehji.1992.635">Tassabehji et al 1992</a>]. Multiple abnormal variants in different populations [<a class="bk_pop" href="#ws1.REF.chen.2010.70">Chen et al 2010</a>, <a class="bk_pop" href="#ws1.REF.pingault.2010.391">Pingault et al 2010</a>, <a class="bk_pop" href="#ws1.REF.wang.2010.1146">Wang et al 2010</a>, <a class="bk_pop" href="#ws1.REF.matsunaga.2013.345">Matsunaga et al 2013</a>] &#x02013; including multiple pathogenic variants within <i>PAX3</i> causing WS1, WS1 with spina bifida, WS3, and craniofacial-deafness-hand syndrome (CDHS) (OMIM <a href="http://omim.org/entry/122880" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">122880</a>) &#x02013; have been described (see <a href="#ws1.Clinical_Description">Clinical Description</a>, <a href="#ws1.Differential_Diagnosis">Differential Diagnosis</a>, and <a href="#ws1.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>).</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<a class="bk_pop" href="#ws1.REF.bondurand.2000.1907">Bondurand et al [2000]</a> showed that an interaction among <i>PAX3</i>, <i>SOX10</i>, and <i>MITF</i> in the regulation of melanocyte development affects a molecular pathway leading to the auditory-pigmentary abnormalities seen in WS. Given the marked variability in expression of phenotypic features among family members having the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the potential role of modifier genes may be significant. <a class="bk_pop" href="#ws1.REF.satojin.2008.1155">Sato-Jin et al [2008]</a> further added to this research by demonstrating that <i>EDNRB</i> expression was dependent on <i>MITF</i>. In addition, they found that <i>EDN</i> directly stimulates the expression of melanocytic pigmentation in an <i>MITF</i>-dependent fashion.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The paired box protein Pax3 is an essential regulator of muscle and neural crest-derived cell types, including melanocytes. Analysis of <i>PAX3</i> pathogenic variants observed in WS1 revealed varying ability of <i>PAX3</i> to bind to and regulate reporter genes fused to either the <i>MITF</i> or TRP-1 (tyrosinase-related protein 1) promoters [<a class="bk_pop" href="#ws1.REF.corry.2005.427">Corry &#x00026; Underhill 2005</a>]. Hence, Pax3 appears to be able to regulate target genes through alternate modes of DNA recognition that are dependent on the specific pathogenic variants. <a class="bk_pop" href="#ws1.REF.corry.2008.1825">Corry et al [2008]</a> showed that the subnuclear localization and altered mobility of the mutated Pax3 protein is a key determinant in its dysfunction. <a class="bk_pop" href="#ws1.REF.birrane.2009.1148">Birrane et al [2009]</a> further demonstrated that certain <i>PAX3</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants could destabilize the folding of the Pax3 homeodomain, whereas others affect its interaction with DNA. <a class="bk_pop" href="#ws1.REF.wu.2015.20556">Wu et al [2015]</a> have examined the loading of <i>PAX3</i> on mitotic chromosomes in zebrafish and suggest that mutated <i>PAX3</i> proteins have dominant negative effects.</p><div id="ws1.Cancer_and_Benign_Tumors"><h4>Cancer and Benign Tumors</h4><p>Somatic <i>PAX3</i> variants have been observed in alveolar rhabdomyosarcoma. <i>PAX3</i> can fuse with <i>FKHR</i>, this fusion creating a gain of function that results in alveolar rhabdomyosarcoma [<a class="bk_pop" href="#ws1.REF.wang.2008.2281">Wang et al 2008</a>]. Individuals with alveolar rhabdomyosarcoma resulting from this mechanism do not have WS1.</p></div></div></div><div id="ws1.References"><h2 id="_ws1_References_">References</h2><div id="ws1.Published_Guidelines__Consensus_Stat"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ws1.REF1">American College of Medical Genetics. Statement on universal newborn hearing screening. Available <a href="http://www.acmg.net/PDFLibrary/Universal-Newborn-Hearing-Screening.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2000. Accessed 7-19-18.</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF2">American College of Medical Genetics Genetic Evaluation of Congenital Hearing Loss Expert Panel. Genetics evaluation guidelines for the etiologic diagnosis of congenital hearing loss. Available <a href="/pmc/articles/PMC3110944/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2002. Accessed 7-19-18.</div></li></ul></div><div id="ws1.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.amirsalari.2012.2179">Amirsalari S, Ajallouyean M, Saburi A, Haddadi Fard A, Abed M, Ghazavi Y. Cochlear implantation outcomes in children with Waardenburg syndrome. <span><span class="ref-journal">Eur Arch Otorhinolaryngol. </span>2012;<span class="ref-vol">269</span>:2179–83.</span> [<a href="/pubmed/22159916" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22159916</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.asher.1996.30">Asher JH, Sommer A, Morell R, Friedman TB. Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome. <span><span class="ref-journal">Hum Mutat. </span>1996;<span class="ref-vol">7</span>:30–5.</span> [<a href="/pubmed/8664898" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8664898</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.baldwin.1992.637">Baldwin CT, Hoth CF, Amos JA, da-Silva EO, Milunsky A. An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome. <span><span class="ref-journal">Nature. </span>1992;<span class="ref-vol">355</span>:637–8.</span> [<a href="/pubmed/1347149" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1347149</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.birrane.2009.1148">Birrane G, Soni A, Ladias JA. Structural basis for DNA recognition by the human PAX3 homeodomain. <span><span class="ref-journal">Biochemistry. </span>2009;<span class="ref-vol">48</span>:1148–55.</span> [<a href="/pubmed/19199574" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19199574</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.black.2001.188">Black FO, Pesznecker SC, Allen K, Gianna C. A vestibular phenotype for Waardenburg syndrome? <span><span class="ref-journal">Otol Neurotol. </span>2001;<span class="ref-vol">22</span>:188–94.</span> [<a href="/pubmed/11300267" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11300267</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.bondurand.2007.1169">Bondurand N, Dastot-Le Moal F, Stanchina L, Collot N, Baral V, Marlin S, Attie-Bitach T, Giurgea I, Skopinski L, Reardon W, Toutain A, Sarda P, Echaieb A, Lackmy-Port-Lis M, Touraine R, Amiel J, Goossens M, Pingault V. Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>:1169–85.</span> [<a href="/pmc/articles/PMC2276340/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2276340</span></a>] [<a href="/pubmed/17999358" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17999358</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.bondurand.2000.1907">Bondurand N, Pingault V, Goerich DE, Lemort N, Sock E, Caignec CL, Wegner M, Goossens M. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2000;<span class="ref-vol">9</span>:1907–17.</span> [<a href="/pubmed/10942418" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10942418</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.brezo.2014.1512">Brezo J, Lam C, Vilain E, Quintero-Rivera F. Phenotypic variability in Waardenburg syndrome resulting from a 22q12.3-q13.1 microdeletion involving SOX10. <span><span class="ref-journal">Am J Med Genet Part A. </span>2014;<span class="ref-vol">164A</span>:1512–9.</span> [<a href="/pubmed/24715709" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24715709</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.chaoui.2011.1436">Chaoui A, Watanabe Y, Touraine R, Baral V, Goossens M, Pingault V, Bondurand N. Identification and functional analysis of SOX10 missense mutations in different subtypes of Waardenburg syndrome. <span><span class="ref-journal">Hum Mut. </span>2011;<span class="ref-vol">32</span>:1436–49.</span> [<a href="/pubmed/21898658" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21898658</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.chen.2010.70">Chen H, Jiang L, Xie Z, Mei L, He C, Hu Z, Xia K, Feng Y. Novel mutations of PAX3, MITF, and SOX10 genes in Chinese patients with type I or type II Waardenburg syndrome. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2010;<span class="ref-vol">397</span>:70–4.</span> [<a href="/pubmed/20478267" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20478267</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.corry.2008.1825">Corry GN, Hendzel MJ, Underhill DA. Subnuclear localization and mobility are key indicators of PAX3 dysfunction in Waardenburg syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2008;<span class="ref-vol">17</span>:1825–37.</span> [<a href="/pubmed/18325909" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18325909</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.corry.2005.427">Corry GN, Underhill DA. Pax3 target gene recognition occurs through distinct modes that are differentially affected by disease-associated mutations. <span><span class="ref-journal">Pigment Cell Res. </span>2005;<span class="ref-vol">18</span>:427–38.</span> [<a href="/pubmed/16280008" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16280008</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.de_sousa_andrade.2012.1375">de Sousa Andrade SM, Monteiro AR, Martins JH, Alves MC, Santos Silva LF, Quadros JM, Ribeiro CA. Cochlear implant rehabilitation outcomes in Waardenburg syndrome children. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>2012;<span class="ref-vol">76</span>:1375–8.</span> [<a href="/pubmed/22784507" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22784507</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.destefano.1998.499">DeStefano AL, Cupples LA, Arnos KS, Asher JH, Baldwin CT, Blanton S, Carey ML, da Silva EO, Friedman TB, Greenberg J, Lalwani AK, Milunsky A, Nance WE, Pandya A, Ramesar RS, Read AP, Tassabejhi M, Wilcox ER, Farrer LA. Correlation between Waardenburg syndrome phenotype and genotype in a population of individuals with identified PAX3 mutations. <span><span class="ref-journal">Hum Genet. </span>1998;<span class="ref-vol">102</span>:499–506.</span> [<a href="/pubmed/9654197" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9654197</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.elmalehberg_s.2013.1257">Elmaleh-Berg&#x000e8;s M, Baumann C, Noel-Petroff N, Sekkal A, Couloigner V, Devriendt K, Wilson M, Marlin S, Sebag G, Pingault V. Spectrum of temporal bone abnormalities in patients with Waardenburg syndrome and SOX10 mutations. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2013;<span class="ref-vol">34</span>:1257–63.</span> [<a href="/pubmed/23237859" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23237859</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.farrer.1992.902">Farrer LA, Grundfast KM, Amos J, Arnos KS, Asher JH, Beighton P, Diehl SR, Fex J, Foy C, Friedman TB, et al.  Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: first report of the WS consortium. <span><span class="ref-journal">Am J Hum Genet. </span>1992;<span class="ref-vol">50</span>:902–13.</span> [<a href="/pmc/articles/PMC1682585/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1682585</span></a>] [<a href="/pubmed/1349198" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1349198</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.fleming.1998.2107">Fleming A, Copp AJ. Embryonic folate metabolism and mouse neural tube defects. <span><span class="ref-journal">Science. </span>1998;<span class="ref-vol">280</span>:2107–9.</span> [<a href="/pubmed/9641914" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9641914</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.gad.2008.1880">Gad A, Laurino M, Maravilla KR, Matsushita M, Raskind WH. Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome? <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:1880–5.</span> [<a href="/pmc/articles/PMC2533638/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2533638</span></a>] [<a href="/pubmed/18553554" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18553554</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.hoth.1993.455">Hoth CF, Milunsky A, Lipsky N, Sheffer R, Clarren SK, Baldwin CT. Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). <span><span class="ref-journal">Am J Hum Genet. </span>1993;<span class="ref-vol">52</span>:455–62.</span> [<a href="/pmc/articles/PMC1682157/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1682157</span></a>] [<a href="/pubmed/8447316" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8447316</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.iso.2008.2162">Iso M, Fukami M, Horikawa R, Azuma N, Kawashiro N, Ogata T. SOX10 mutation in Waardenburg syndrome type II. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:2162–3.</span> [<a href="/pubmed/18627047" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18627047</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.jan.2008.744">Jan IA, Stroedter L, Haq AU, Din ZU. Association of Shah-Waardenburgh syndrome: a review of 6 cases. <span><span class="ref-journal">J Pediatr Surg. </span>2008;<span class="ref-vol">43</span>:744–7.</span> [<a href="/pubmed/18405726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18405726</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.jones.1975.84">Jones KL, Smith DW, Harvey MA, Hall BD, Quan L. Older paternal age and fresh gene mutation: data on additional disorders. <span><span class="ref-journal">J Pediatr. </span>1975;<span class="ref-vol">86</span>:84–8.</span> [<a href="/pubmed/1110452" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1110452</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.kapur.1991.194">Kapur S, Karam S. Germ-line mosaicism in Waardenburg syndrome. <span><span class="ref-journal">Clin Genet. </span>1991;<span class="ref-vol">39</span>:194–8.</span> [<a href="/pubmed/2036740" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2036740</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.koyama.2016.2854736">Koyama H, Kashio A, Sakata A, Tsutsumiuchi K, Matsumoto Y, Karino S, Kakigi A, Iwasaki S, Yamasoba T. The hearing outcomes of cochlear implantation in Waardenburg syndrome. <span><span class="ref-journal">Biomed Res Int. </span>2016;<span class="ref-vol">2016</span>:2854736.</span> [<a href="/pmc/articles/PMC4916269/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4916269</span></a>] [<a href="/pubmed/27376080" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27376080</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.kujat.2007.155">Kujat A, Veith VP, Faber R, Froster UG. Prenatal diagnosis and genetic counseling in a case of spina bifida in a family with Waardenburg syndrome type I. <span><span class="ref-journal">Fetal Diagn Ther. </span>2007;<span class="ref-vol">22</span>:155–8.</span> [<a href="/pubmed/17139175" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17139175</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.l_ger.2012.584">L&#x000e9;ger S, Balguerie X, Goldenberg A, Drouin-Garraud V, Cabot A, Amstutz-Montadert I, Young P, Joly P, Bodereau V, Holder-Espinasse M, Jamieson RV, Krause A, Chen H, Baumann C, Nunes L, Dollfus H, Goossens M, Pingault V. Novel and recurrent non-truncating mutations of the MITF basic domain: genotypic and phenotypic variations in Waardenburg and Tietz syndromes. <span><span class="ref-journal">Eur J Hum Genet. </span>2012;<span class="ref-vol">20</span>:584–7.</span> [<a href="/pmc/articles/PMC3330215/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3330215</span></a>] [<a href="/pubmed/22258527" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22258527</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.lemay.2015.493">Lemay P, Guyot MC, Tremblay &#x000c9;, Dionne-Laporte A, Spiegelman D, Henrion &#x000c9;, Diallo O, De Marco P, Merello E, Massicotte C, D&#x000e9;silets V, Michaud JL, Rouleau GA, Capra V, Kibar Z. Loss-of-function de novo mutations play an important role in severe human neural tube defects. <span><span class="ref-journal">J Med Genet. </span>2015;<span class="ref-vol">52</span>:493–7.</span> [<a href="/pubmed/25805808" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25805808</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.liu.1995.95">Liu XZ, Newton VE, Read AP. Waardenburg syndrome type II: phenotypic findings and diagnostic criteria. <span><span class="ref-journal">Am J Med Genet. </span>1995;<span class="ref-vol">55</span>:95–100.</span> [<a href="/pubmed/7702105" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7702105</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.madden.2003.2035">Madden C, Halsted MJ, Hopkin RJ, Choo DI, Benton C, Greinwald JH Jr. Temporal bone abnormalities associated with hearing loss in Waardenburg syndrome. <span><span class="ref-journal">Laryngoscope. </span>2003;<span class="ref-vol">113</span>:2035–41.</span> [<a href="/pubmed/14603070" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14603070</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.matsunaga.2013.345">Matsunaga T, Mutai H, Namba K, Morita N, Masuda S. Genetic analysis of PAX3 for diagnosis of Waardenburg syndrome type I. <span><span class="ref-journal">Acta Otolaryngol. </span>2013;<span class="ref-vol">133</span>:345–51.</span> [<a href="/pubmed/23163891" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23163891</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.merchant.2001.875">Merchant SN, McKenna MJ, Baldwin CT, Milunsky A, Nadol JB Jr. Otopathology in a case of type I Waardenburg's syndrome. <span><span class="ref-journal">Ann Otol Rhinol Laryngol. </span>2001;<span class="ref-vol">110</span>:875–82.</span> [<a href="/pubmed/11558766" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11558766</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.milunsky.2007.179">Milunsky JM, Maher TA, Ito M, Milunsky A. The value of MLPA in Waardenburg syndrome. <span><span class="ref-journal">Genet Test. </span>2007;<span class="ref-vol">11</span>:179–82.</span> [<a href="/pubmed/17627390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17627390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.newton.2002.201">Newton VE. Clinical features of the Waardenburg syndromes. <span><span class="ref-journal">Adv Otorhinolaryngol. </span>2002;<span class="ref-vol">61</span>:201–8.</span> [<a href="/pubmed/12408085" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12408085</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.ohtani.2006.491">Ohtani S, Skinkai Y, Horibe A, Katayama K, Tsuji T, Matsushima Y, Tachibana M, Kunieda T. A deletion in the endothelin-B receptor gene is responsible for the Waardenburg syndrome-like phenotypes of WS4 mice. <span><span class="ref-journal">Exp Anim. </span>2006;<span class="ref-vol">55</span>:491–5.</span> [<a href="/pubmed/17090968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17090968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.pardono.2003.223">Pardono E, van Bever Y, van den Ende J, Havrenne PC, Iughetti P, Maestrelli SR, Costa F O, Richieri-Costa A, Frota-Pessoa O, Otto PA. Waardenburg syndrome: clinical differentiation between types I and II. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">117A</span>:223–35.</span> [<a href="/pubmed/12599185" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12599185</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.pingault.2010.391">Pingault V, Ente D, Dastot-Le Moal F, Goossens M, Marlin S, Bondurand N. Review and update of mutations causing Waardenburg syndrome. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:391–406.</span> [<a href="/pubmed/20127975" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20127975</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.preus.1983.383">Preus M, Linstrom C, Polomeno RC, Milot J. Waardenburg syndrome--penetrance of major signs. <span><span class="ref-journal">Am J Med Genet. </span>1983;<span class="ref-vol">15</span>:383–8.</span> [<a href="/pubmed/6881207" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6881207</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.s_nchezmart_n.2003.125">S&#x000e1;nchez-Mart&#x000ed;n M, P&#x000e9;rez-Losada J, Rodr&#x000ed;guez-Garc&#x000ed;a A, Gonz&#x000e1;lez-S&#x000e1;nchez B, Korf BR, Kuster W, Moss C, Spritz RA, S&#x000e1;nchez-Garc&#x000ed;a I. Deletion of the SLUG (SNAI2) gene results in human piebaldism. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">122A</span>:125–32.</span> [<a href="/pubmed/12955764" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12955764</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.satojin.2008.1155">Sato-Jin K, Nishimura EK, Akasaka E, Huber W, Nakano H, Miller A, Du J, Wu M, Hanada K, Sawamura D, Fisher DE, Imokawa G. Epistatic connections between micropthalmia-associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders. <span><span class="ref-journal">FASEB J. </span>2008;<span class="ref-vol">22</span>:1155–68.</span> [<a href="/pubmed/18039926" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18039926</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.shields.2013.1167">Shields CL, Nickerson SJ, Al-Dahmash S, Shields JA. Waardenburg syndrome: iris and choroidal hypopigmentation: findings on anterior and posterior segment imaging. <span><span class="ref-journal">JAMA Ophthalmol. </span>2013;<span class="ref-vol">131</span>:1167–73.</span> [<a href="/pubmed/23868078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23868078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.sommer.2003.91">Sommer A, Bartholomew DW. Craniofacial-deafness-hand syndrome revisited. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">123A</span>:91–4.</span> [<a href="/pubmed/14556253" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14556253</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.sznajer.2008.1038">Sznajer Y, Coldea C, Meire F, Delpierre I, Sekhara T, Touraine RL. A de novo SOX10 mutation causing severe type 4 Waardenburg syndrome without Hirschsprung disease. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:1038–41.</span> [<a href="/pubmed/18348267" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18348267</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.tamayo.2008.1026">Tamayo ML, Gelvez N, Rodriguez M, Florez S, Varon C, Medina D, Bernal JE. Screening program for Waardenburg syndrome in Colombia: clinical definition and phenotypic variability. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:1026–31.</span> [<a href="/pubmed/18241065" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18241065</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.tassabehji.1992.635">Tassabehji M, Read AP, Newton VE, Harris R, Balling R, Gruss P, Strachan T. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. <span><span class="ref-journal">Nature. </span>1992;<span class="ref-vol">355</span>:635–6.</span> [<a href="/pubmed/1347148" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1347148</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.waardenburg.1951.195">Waardenburg PJ. A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness. <span><span class="ref-journal">Am J Hum Genet. </span>1951;<span class="ref-vol">3</span>:195–253.</span> [<a href="/pmc/articles/PMC1716407/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1716407</span></a>] [<a href="/pubmed/14902764" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14902764</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.wang.2010.1146">Wang J, Li S, Xiao X, Wang P, Guo X, Zhang Q. PAX3 mutations and clinical characteristics in Chinese patients with Waardenburg syndrome type 1. <span><span class="ref-journal">Mol Vis. </span>2010;<span class="ref-vol">16</span>:1146–53.</span> [<a href="/pmc/articles/PMC2901192/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2901192</span></a>] [<a href="/pubmed/20664692" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20664692</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.wang.2008.2281">Wang Q, Fang WH, Krupinski J, Kumar S, Slevin M, Kumar P. Pax genes in embryogenesis and oncogenesis. <span><span class="ref-journal">J Cell Mol Med. </span>2008;<span class="ref-vol">12</span>:2281–94.</span> [<a href="/pmc/articles/PMC4514106/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4514106</span></a>] [<a href="/pubmed/18627422" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18627422</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.wildhardt.2013">Wildhardt G, Zirn B, Graul-Neumann LM, Wechtenbruch J, Suckfull M, Buske A, Bohring A, Kubisch C, Vogt S, Strobl-Wildemann G, Greally M, Bartsch O, Steinberger D. Spectrum of novel mutations found in Waardenburg syndrome types 1 and 2: implications for molecular genetic diagnostics. <span><span class="ref-journal">BMJ Open. </span>2013;<span class="ref-vol">3</span>(3)</span>  [<a href="/pmc/articles/PMC3612789/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3612789</span></a>] [<a href="/pubmed/23512835" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23512835</span></a>] [<a href="http://dx.crossref.org/10.1136/bmjopen-2012-001917" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CrossRef</a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.wollnik.2003.42">Wollnik B, Tukel T, Uyguner O, Ghanbari A, Kayserili H, Emiroglu M, Yuksel-Apak M. Homozygous and heterozygous inheritance of PAX3 mutations causes different types of Waardenburg syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">122A</span>:42–5.</span> [<a href="/pubmed/12949970" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12949970</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.wu.2015.20556">Wu TF, Yao YL, Lai IL, Lai CC, Lin PL, Yang WM. Loading of PAX3 to Mitotic Chromosomes Is Mediated by Arginine Methylation and Associated with Waardenburg Syndrome. <span><span class="ref-journal">J Biol Chem. </span>2015;<span class="ref-vol">290</span>:20556–64.</span> [<a href="/pmc/articles/PMC4536459/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4536459</span></a>] [<a href="/pubmed/26149688" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26149688</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.yang.2013.e77149">Yang S, Dai P, Liu X, Kang D, Zhang X, Yang W, Zhou C, Yang S, Yuan H. Genetic and phenotypic heterogeneity in Chinese patients with Waardenburg syndrome type II. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e77149.</span> [<a href="/pmc/articles/PMC3806753/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3806753</span></a>] [<a href="/pubmed/24194866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24194866</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.zhang.2012.491">Zhang H, Chen H, Luo H, An J, Sun L, Mei L, He C, Jiang L, Jiang W, Xia K, Li JD, Feng Y. Functional analysis of Waardenburg syndrome-associated PAX3 and SOX10 mutations: report of a dominant-negative SOX10 mutation in Waardenburg syndrome type II. <span><span class="ref-journal">Hum Genet. </span>2012;<span class="ref-vol">131</span>:491–503.</span> [<a href="/pubmed/21965087" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21965087</span></a>]</div></li></ul></div><div id="ws1.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ws1.REF.vicenteduenas.2005">Vicente-Duenas C, Bermejo-Rodriguez C, Perez-Caro M, Gonzalez-Herrero I, Sanchez-Martin M, Sanchez-Garcia I. Waardenburg syndrome (WS). Atlas of Genetics and Cytogenetics Oncology and Haematology. Available <a href="http://atlasgeneticsoncology.org/Kprones/WaardenburgID10089.html" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2005. Accessed 7-19-18.</div></li></ul></div></div><div id="ws1.Chapter_Notes"><h2 id="_ws1_Chapter_Notes_">Chapter Notes</h2><div id="ws1.Author_Notes"><h3>Author Notes</h3><p>Dr Milunsky was previously a Professor in the Department of Pediatrics, Genetics, and Genomics at Boston University School of Medicine. He is currently the Co-Director of the Center for Human Genetics, Inc (Cambridge, MA), where he also serves as Senior Molecular Director and Director of Clinical Genetics. His interest in Waardenburg syndrome predates the identification of <i>PAX3</i>, when he was involved in <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> mapping of several families with WS1.</p></div><div id="ws1.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>4 May 2017 (sw) Revision: <a href="/books/NBK1531/bin/ws1-W_index_calculator.xlsx">W index calculator tool</a> added</div></li><li class="half_rhythm"><div>12 January 2017 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 August 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 December 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>4 August 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 April 2007 (jm) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> clinically available</div></li><li class="half_rhythm"><div>17 January 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 October 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 July 2001 (me) Review posted live</div></li><li class="half_rhythm"><div>12 February 2001 (jm) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1531</span><span class="label">PMID: <a href="/pubmed/20301703" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301703</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/wfs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/warsaw/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1531&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1531/?report=reader">PubReader</a></li><li><a href="/books/NBK1531/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1531" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1531" style="display:none" title="Cite this Page"><div class="bk_tt">Milunsky JM. Waardenburg Syndrome Type I. 2001 Jul 30 [Updated 2017 May 4]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1531/pdf/Bookshelf_NBK1531.pdf">PDF version of this page</a> (448K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ws1.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ws1.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ws1.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ws1.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ws1.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ws1.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ws1.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ws1.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ws1.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ws1.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ws1.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5077[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PAX3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1461558" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1461558" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1461558" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1461558" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26275939" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Molecular and clinical characterization of Waardenburg syndrome type I in an Iranian cohort with two novel PAX3 mutations.</a><span class="source">[Gene. 2015]</span><div class="brieflinkpop offscreen_noflow">Molecular and clinical characterization of Waardenburg syndrome type I in an Iranian cohort with two novel PAX3 mutations.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jalilian N, Tabatabaiefar MA, Farhadi M, Bahrami T, Emamdjomeh H, Noori-Daloii MR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Gene. 2015 Dec 15; 574(2):302-7. Epub 2015 Aug 11.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26279250" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A novel mutation in the PAX3 gene causes Waardenburg syndrome type I in an Iranian family.</a><span class="source">[Int J Pediatr Otorhinolaryngol...]</span><div class="brieflinkpop offscreen_noflow">A novel mutation in the PAX3 gene causes Waardenburg syndrome type I in an Iranian family.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jalilian N, Tabatabaiefar MA, Farhadi M, Bahrami T, Noori-Daloii MR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Int J Pediatr Otorhinolaryngol. 2015 Oct; 79(10):1736-40. Epub 2015 Aug 3.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21915450" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">[Waardenburg syndrome type I: case report].</a><span class="source">[Arq Bras Oftalmol. 2011]</span><div class="brieflinkpop offscreen_noflow">[Waardenburg syndrome type I: case report].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Silva PC, Rangel P, Couto A Jr. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Arq Bras Oftalmol. 2011 May-Jun; 74(3):209-10. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301750" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WFS1</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WFS1</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tranebjærg L, Barrett T, Rendtorff ND. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301557" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Noonan Syndrome with Multiple Lentigines</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Noonan Syndrome with Multiple Lentigines<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gelb BD, Tartaglia M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301703" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301703" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042b7adde0891169d2615c">Waardenburg Syndrome Type I - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Waardenburg Syndrome Type I - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:39:38-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D7591E0415381000000000A0503E2&amp;ncbi_session=CE8D7591E042B791_2565SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1531%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1531&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1531/&amp;ncbi_pagename=Waardenburg Syndrome Type I - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D7591E042B791_2565SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>